menu
    • menu

    Company profile for Biocon Biologics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilar organization. It is leveraging cutting-edge science, innovative tech platforms, and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six mol...
    Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilar organization. It is leveraging cutting-edge science, innovative tech platforms, and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like the United States, EU, Australia, Canada, and Japan.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biocon Biologicsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Biocon House, Semicon Park Electronics City, Phase – II, Hosur Road Bengalur...
    Telephone
    Telephone
    +91 8067756775
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioconbiologics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioconbiologics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocon Biologics Gets Global Rights For Biosimilar Adalimumab
    Biocon Biologics Gets Global Rights For Biosimilar Adalimumab

    23 Dec 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-biologics-gets-global-rights-for-biosimilar-adalimumab/articleshow/126140085.cms

    ECONOMICTIMES
    23 Dec 2025
    Share Share
    Biocon Biologics Named 2025 Asia IP Elite By IAM For 9Th Year
    Biocon Biologics Named 2025 Asia IP Elite By IAM For 9Th Year

    18 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/biocon-biologics-honored-as-2025-asia-ip-elite-by-iam-for-9th-consecutive-year-18593

    INDPHARMAPOST
    18 Dec 2025
    Share Share
    Biocon Biologics Inks Deal To Market Biosimilar Aflibercept
    Biocon Biologics Inks Deal To Market Biosimilar Aflibercept

    14 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/biocon-biologics-signs-settlement-and-lcense-agreement-to-commercialize-biosimilar-aflibercept-18553

    INDPHARMAPOST
    14 Dec 2025
    Share Share
    Biocon To Merge Biocon Biologics In $5.5 Billion Deal
    Biocon To Merge Biocon Biologics In $5.5 Billion Deal

    06 Dec 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/indias-biocon-make-biocon-biologics-wholly-owned-subsidiary-2025-12-06/

    REUTERS
    06 Dec 2025
    Share Share
    Biocon Biologics Sets Denosumab Biosimilar Market Entry
    Biocon Biologics Sets Denosumab Biosimilar Market Entry

    03 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/biocon-biologics-secures-market-entry-date-for-denosumab-biosimilars-in-europe-rest-of-the-world-18433

    INDPHARMAPOST
    03 Dec 2025
    Share Share
    Biocon Biologics Settles With Amgen For Denosumab Biosimilars
    Biocon Biologics Settles With Amgen For Denosumab Biosimilars

    02 Dec 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/biocon-biologics-reaches-settlement-with-amgen-for-denosumab-biosimilars-commercialisation/

    EXPRESSPHARMA
    02 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Contact Biocon Biologics and get a quotation

    Biocon Biologics is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Insulin bulk offered by Biocon Biologics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search